fincash logo SOLUTIONS

Fincash » Search » Sun Pharmaceuticals Industries Ltd

Sun Pharmaceuticals Industries Ltd

Updated on August 3, 2020

Stock/Share Code - SUNPHARMA

Sun Pharmaceuticals Industries is in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs).

Below is the details of SUNPHARMA Sun Pharmaceuticals Industries Ltd

Market Cap₹113,788 Cr.
Current Price ₹525.95 as on 7 Aug 20
52 Week High / Low Price₹504.85 / ₹312
Face Value₹1
Stock P/E35.44
Book Value₹101.68
Dividend Yield0.63 %
ROCE7.90 %
ROE8.26 %
Sales Growth (3yrs)10.10 %
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has good consistent profit growth of 101.65% over 5 years
Cons: Stock is trading at 4.66 times its book value Tax rate seems low Company has a low return on equity of 4.13% for last 3 years. Earnings include an other income of Rs.1510.92 Cr. Company has high debtors of 178.24 days.

Sun Pharmaceuticals Industries Ltd Price Chart

Sun Pharmaceuticals Industries Ltd Price Chart

Sun Pharmaceuticals Industries Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹180.85 35.44 ₹113,788.46 Cr. 0.63 ₹1,155.85 Cr. 8.22 11.13 2836.08 7.90
2. Dr Reddy's Labs ₹4,573.5 33.39 ₹67,652.81 Cr. 0.49 ₹781.1 Cr. 71.52 10.41 4448.90 12.42
3. Cipla ₹728.65 33.79 ₹52,256.4 Cr. 0.46 ₹245.95 Cr. -33.02 -0.63 4376.19 10.94
4. Aurobindo Pharma ₹906.45 16.67 ₹43,690.51 Cr. 0.40 ₹705.45 Cr. -2.26 11.87 5895.00 18.45
5. Biocon ₹399.45 62.53 ₹42,564 Cr. 0.14 ₹123.4 Cr. -42.26 3.41 1581.00 13.39
6. Torrent Pharma. ₹46.15 39.00 ₹39,979.07 Cr. 0.72 ₹314 Cr. 121.13 4.85 1946.00 12.66
7. Cadila Health. ₹390.9 25.02 ₹35,278.17 Cr. 1.02 ₹373.9 Cr. -26.54 1.68 3638.10 15.35
8. Alkem Lab ₹2,981.95 24.26 ₹27,056.36 Cr. 0.97 ₹381.98 Cr. 88.60 13.26 2181.84 16.58

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Sun Pharmaceuticals Industries Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020
Sales -1,7951,8242,4082,6813,0172,4732,2612,5523,3093,3733,0142,836
YOY Sales Growth %-0.26%-10.27%23.51%33.04%68.02%35.61%-6.11%-4.80%9.70%36.39%33.27%11.13%
Expenses -1,9631,9071,9362,1452,1622,3052,0871,9942,3672,5382,3082,608
Material Cost %45.26%49.35%38.74%32.88%27.67%36.12%43.40%37.77%32.18%36.09%36.67%41.62%
Employee Cost %23.06%21.55%16.84%15.23%12.25%15.55%17.30%16.69%12.89%12.83%14.07%14.79%
Operating Profit-168-84472536855169175558942835706229
OPM %-9%-5%20%20%28%7%8%22%28%25%23%8%
Other Income-9258923317731-6812867919258151,219
Profit before tax-1,286574321479594-795-659867688404781,167
Tax %-0%-1%0%-5%0%-1%41%-8%1%2%2%1%
Net Profit-1,288577321505593-806-391,0687638234691,156
EPS in Rs-5.372.411.342.102.47-3.36-0.164.453.183.431.954.82

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales -3,0873,7802,4863,1084,0162,4322,8298,0287,7197,6848,98210,30312,532
Sales Growth %40.86%22.44%-34.24%25.03%29.22%-39.43%16.31%183.81%-3.85%-0.46%16.90%14.70%
Expenses -2,1132,6081,5571,7832,4271,9192,8918,5878,2087,5708,1408,7109,820
Material Cost %49.46%50.53%32.80%28.86%26.33%36.85%37.65%43.76%38.78%42.91%39.75%35.65%
Manufacturing Cost %3.24%3.51%5.72%7.28%7.47%16.03%16.24%13.95%15.67%15.84%13.85%12.67%
Employee Cost %3.89%3.92%7.03%8.40%7.88%9.66%9.89%18.53%19.13%19.52%18.09%15.25%
Other Cost %11.85%11.02%17.09%12.84%18.76%16.38%38.42%30.71%32.75%20.24%18.93%20.96%
Operating Profit9741,1729291,3241,588513-62-559-4891148421,5932,712
OPM %32%31%37%43%40%21%-2%-7%-6%1%9%15%22%
Other Income13918591194214237-2,6192124455153142201,511
Profit before tax1,0521,2959491,4541,726663-2,801-1,559-1,082-172807193,253
Tax %4%2%5%5%2%22%-1%5%-0%-36%-9%-14%
Net Profit1,0141,2658991,3841,697517-2,829-1,474-1,088-233068173,211
EPS in Rs4.725.884.111.281.570.410.
Dividend Payout %21%23%32%26%26%50%-11%-42%-22%-3,677%157%81%

Compounded Sales Growth

  • 10 Years:: 10.55%
  • 5 Years:: 29.50%
  • 3 Years:: 10.10%
  • TTM:: 21.63%

Compounded Profit Growth

  • 10 Years:: 4.17%
  • 5 Years:: 101.65%
  • 3 Years:: 50.10%
  • TTM:: 58.96%

Return on Equity

  • 10 Years:: 10.77%
  • 5 Years:: -10.85%
  • 3 Years:: -2.70%
  • 1 Year:: 15.71%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Share Capital -104104104104104104207207241240240240240
Equity Capital104104104104104104207207241240240240240
Other Liabilities -1,1021,0337218761,2131,4144,5487,8976,5486,8107,5858,4348,252
Trade Payables6464782242704003633801,5771,7722,0732,5662,1552,335
Advance from Customers6102810600104283540279
Other liability items4495444695968071,0524,1676,2174,7484,7034,9796,0005,917
Total Liabilities5,4126,2086,4697,6079,1319,24614,36437,44634,26633,86936,79237,71438,410
Fixed Assets -6306997417949771,1361,2673,1853,5754,0394,6454,9785,441
Gross Block9351,0621,1601,2691,4831,7251,9745,9954,1044,9886,5737,461
Accumulated Depreciation3043614164745065897062,8105299491,9282,483
Other Assets -2,8062,7381,5843,0153,4673,4455,6017,2947,5529,39712,80414,18915,223
Trade receivables1,0556805535437137389801,8031,9982,7155,2715,0316,168
Cash Equivalents9731,265891,2511,328431141416169170155341655
Loans n Advances3943113824664519182,8111,3371,6951,9072,7203,509534
Other asset items-6-6-101373354907501,5481,5582,2972,5222,5165,232
Total Assets5,4126,2086,4697,6079,1319,24614,36437,44634,26633,86936,79237,71438,410

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity -6261,2626461,2321,339106-2,405149-1,254-1,621-1,1711,242
Profit from operations1,0321,1549761,3401,838589-2,758-973-317-68-151,168
Loans Advances00041-49-64-93-520000
Direct taxes-451-49-74-144-169-149-193-353-784-291-37
Other operating items00002943815547-513-261-5101,000
Exceptional CF items000-200000000
Cash from Investing Activity --743-660-159-1,073-7714565172,6423,6402,3811,394431
Fixed assets purchased-99-174-127-245-388-430-434-1,028-564-1,094-746-597
Fixed assets sold0551312151410612
Investments purchased-3,767-6,295-16,934-12,294-13,466-15,363-19,454-10,360-13,197-17,639-16,806-17,098
Investments sold2,9935,68315,69212,63513,18414,77320,19112,19113,25217,65116,83416,883
Interest received10484138114145208106895517144119
Dividends received0000000039204815476
Invest in subsidiaries000-0-381-1,316-616-00000
Loans to subsidiaries000000000-000
Shares acq cancelled000000003,8473,2321,290970
Acquisition of companies00000000-16-1-86-293
Inter corporate deposits4936-111000000000
Other investing items-2401,178-1,2831322,5837231,7362090-58-43
Cash from Financing Activity --6-326-327-312-420-5091,742-2,674-2,368-753-272-1,469
Proceeds from shares0000000759210
Proceeds from borrowings2162100000000
Interest paid fin-5-5-0-1-0-0-18-332-364-144-284-268
Dividends paid-2-207-284-285-352-440-518-310-722-240-798-480
Other financing items-2-115-48-47-67-692,278-2,106-1,291-372809-721
Net Cash Flow-123276160-15314853-145117177-50205

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.


Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %27%27%18%23%25%8%0%-6%-3%-0%5%8%
Debtor Days125668164651111268294129214178
Inventory Turnover8.548.634.705.236.383.

Announcements & News

Recent Announcements

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Sun Pharmaceuticals Industries Ltd & Get More Returns than Bank Deposit

All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.